[O8] Oral Presentations 8

13:55 〜 14:05R&D IIVaccine Science

[O8-05] AI-Guided Dengue Vaccine Development Targeting Humoral and Cellular Immunity

*Shusaku Mizukami^1,2, Sebastian Kjell-Ove Kapell^1,3,4, Shara Bakytbek^1,5, Farzaneh Valanezhad^1,5, Ayako Hyuga^1,5, Shin-Ichi Inoue^1,6, Mya Myat Ngwe Tun^1,7, Haruka Abe^1,8, Yarob Ibraheem^1,5, Vegard Børve Sørdal⁹, Marius Gheorghe⁹, Ioannis Vardaxis⁹, Daiki Mori⁴, Daiki Miura⁴, Yuki Tanaka⁴, Yoko Kuroki^1,10, Shuji Iwashita^1,10, Sayuri Nakamae^1,10, Corazon Cerilla Buerano^1,7, Basu Dev Pandey¹, Taiki Aoshi^1,6, Satoshi Kaneko^1,11, Yuki Takamatsu^1,12, Futoshi Hasebe^1,8, Hitoshi Sasaki^1,10, Kazuhide Onoguchi⁴, Katsuyuki Yui¹³, Trevor Clancy⁹, Kaidre Bendjama⁹, Shinjiro Hamano^1,5, Kouichi Morita¹ (1. Vaccine Research and Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University (Japan), 2. Deptartment of Immune Regulation, SHIONOGI Global Infectious Diseases Division (SHINE), Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 3. Department of Vaccine Informatics, NEKKEN, Nagasaki University (Japan), 4. NEC Corporation (Japan), 5. Department of Parasitology, NEKKEN, Nagasaki University (Japan), 6. Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University (Japan), 7. Department of Tropical Viral Vaccine Development, NEKKEN, Nagasaki University (Japan), 8. Vietnam Research Station, NEKKEN, Nagasaki University (Japan), 9. NEC Oncoimmunity AS (Norway), 10. Department of Clinical Product Development, NEKKEN, Nagasaki University (Japan), 11. Deptartment of Eco-epidemiology, NEKKEN, Nagasaki University (Japan), 12. Department of Virology, NEKKEN, Nagasaki University (Japan), 13. SHINE, NEKKEN, Nagasaki University (Japan))

閲覧にはパスワードが必要です

ログイン

または